AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MESOBLAST LTD

2.320

-0.140-5.69%

Volume:1.37M

Turnover:3.23M

Market Cap:3.01B

PE:-37.45

High:2.450

Open:2.410

Low:2.280

Close:2.460

52wk High:3.310

52wk Low:1.880

Shares:1.30B

Float Shares:786.49M

Volume Ratio:1.16

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.062

EPS(LYR):-0.062

ROE:-9.86%

ROA:-4.11%

PB:3.79

PE(LYR):-37.45

Loading ...

Overview Company News Filings

3 Founder Led Australian Stocks Retail Investors Are Tracking Right Now

Simply Wall St.

3 Australian Founder Led Stocks With Long Term Skin In The Game

Simply Wall St.

Mesoblast Requests Modular Review of BLA for Rexlemestrocel-l in End-stage Heart Failure with LVAD

3 Founder Led ASX Stocks Retail Investors Are Watching For Management Alignment

Simply Wall St.

Why Mesoblast (ASX:MSB) Is Up 9.3% After FDA Accepts Modular BLA Review For Rexlemestrocel-L

Simply Wall St.

Founder Led Stocks Retail Investors Are Watching In Australia Right Now

Simply Wall St.

Is Mesoblast (ASX:MSB) Undervalued Following FDA Progress For Rexlemestrocel L?

Simply Wall St.

Stock Track | Mesoblast Soars 5.12% Intraday on FDA BLA Filing Number for Rexlemestrocel-L Heart Failure Therapy

Mesoblast Receives Biologics License Application Filing Number From US FDA; Shares Up 3%

MT Newswires Live

Mesoblast Wins FDA BLA Filing Number for Rexlemestrocel-l, Seeks Modular Review in LVAD Patients

Mesoblast - Requests Modular Review of Bla for Rexlemestrocel-l in End-stage Heart Failure with Lvad

THOMSON REUTERS

Mesoblast - Rexlemestrocel-l Receives Orphan Drug and Rmat Designations

THOMSON REUTERS

Founder Led Stocks With Long Term Skin In The Game

Simply Wall St.

3 Founder Led Australian Stocks With Insider Skin In The Game

Simply Wall St.

Founder Led Stocks Why Investors Are Looking At Flight Centre And 2 More

Simply Wall St.

3 Promising ASX Penny Stocks With Over A$60M Market Cap

Simply Wall St.

Mesoblast Draws $50 Million From Facility Provided by Shareholder

MT Newswires Live

Press Release: Mesoblast Draws US$50 Million from Five-year Non-dilutive Facility

Mesoblast (ASX:MSB) Is Up 9.2% After Ryoncil’s Near-US$100m Debut And Revascor FDA Progress – Has The Bull Case Changed?

Simply Wall St.

Mesoblast Says JPMorgan Ceases to be Substantial Holder

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/MSB.AU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MSB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","market":"AU","secType":"STK","nameCN":"MESOBLAST LTD","latestPrice":2.32,"timestamp":1788143967054,"preClose":2.46,"halted":0,"volume":1366399,"delay":0,"changeRate":-0.05691056910569111,"nameEN":"MESOBLAST LTD","floatShares":786490638,"shares":1296862776,"eps":-0.061954324035068384,"marketStatus":"Trading","change":-0.14,"latestTime":"08-31 12:40:31 AEST","open":2.41,"high":2.45,"low":2.28,"amount":3225335,"amplitude":0.069106,"askPrice":2.32,"askSize":9686,"bidPrice":2.31,"bidSize":59718,"shortable":3,"etf":0,"ttmEps":-0.061954324035068384,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788156000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":2.46,"openAndCloseTimeList":[[1788134400000,1788156000000]],"volumeRatio":1.160212,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MSB.AU","preClose":2.46,"auctionPrice":2.41,"auctionVolume":51844,"auctionTime":1788134344559,"referenceTime":1787913003093,"auction":1,"marketStatus":"盘前竞价","timestamp":1788134344559}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","floatShares":786490638,"roa":"-4.11%","roe":"-9.86%","lyrEps":-0.061954,"volumeRatio":1.160212,"shares":1296862776,"dividePrice":0,"high":2.45,"amplitude":0.069106,"preClose":2.46,"low":2.28,"week52Low":1.88,"pbRate":"3.79","psRate":"17.93","week52High":3.31,"institutionHeld":0,"latestPrice":2.32,"committee":0.720881,"eps":-0.061954324035068384,"divideRate":0,"volume":1366399,"delay":0,"ttmEps":-0.061954324035068384,"open":2.41,"prevYearClose":2.72,"prevWeekClose":2.46,"prevMonthClose":2.05,"prevQuarterClose":1.955,"fiveDayClose":2.35,"twentyDayClose":2.03,"sixtyDayClose":2.05,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787702400000,"name":null,"time":"","dateTimestamp":1787666400000,"actualEps":null},{"date":"2025-02-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSB.AU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2650945914","title":"3 Founder Led Australian Stocks Retail Investors Are Tracking Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2650945914","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650945914?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:33","pubTimestamp":1783564382,"startTime":"0","endTime":"0","summary":"With inflation worries, oil shocks and shifting interest rate expectations back in focus, many investors are looking for leaders who are personally invested in how their companies perform. Founder led stocks can offer exactly that, with management teams whose own legacies and wealth are closely tied to long term results. The Founder-Led Companies screener is designed to surface these businesses so you are not just backing an idea; you are backing the people behind it. Below, the article will...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-retail-investors-are-trackin-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-retail-investors-are-trackin-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ZYAU.AU","IISV.AU","XAO.AU","MQG.AU","VAS.AU","BK7042","EIGA.AU","VAP.AU","BK7508","XKO.AU","BK7043","IIGF.AU","BK7511","BK7067","MAQ.AU","BK4211","MSB.AU","IMLC.AU","QRE.AU","BK7046","IOZ.AU","E200.AU","OZF.AU","QFN.AU","BK7070","DACE.AU","ISBC","BEAR.AU","XJO.AU","FLT.AU","GIVE.AU","BBOZ.AU","BK7501","GEAR.AU","OZR.AU","STW.AU","SLF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649987762","title":"3 Australian Founder Led Stocks With Long Term Skin In The Game","url":"https://stock-news.laohu8.com/highlight/detail?id=2649987762","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649987762?lang=en_us&edition=fundamental","pubTime":"2026-07-07 17:29","pubTimestamp":1783416553,"startTime":"0","endTime":"0","summary":"With inflation risks tied to oil supply tensions, shifting rate expectations in the UK and mixed signals from central banks worldwide, many investors are looking for company level resilience rather than macro calls. Founder led businesses can offer that, as leaders with large personal stakes often think in terms of decades, not quarters. This Founder Led Companies screener focuses on those entrepreneurs and original builders who are still at the helm and deeply invested in outcomes. In this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-australian-founder-led-stocks-with-long-term-skin-in-the-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-australian-founder-led-stocks-with-long-term-skin-in-the-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VAP.AU","STW.AU","BK7043","FLT.AU","E200.AU","BK7046","MAQ.AU","EIGA.AU","MSB.AU","BBOZ.AU","AIPO","DACE.AU","BK7511","IOZ.AU","QFN.AU","XAO.AU","ZYAU.AU","BK7501","XKO.AU","BEAR.AU","OZF.AU","OZR.AU","IMLC.AU","GEAR.AU","VAS.AU","IIGF.AU","BK7067","QRE.AU","MQG.AU","SLF.AU","BK7508","BK7070","BK7042","IISV.AU","XJO.AU","GIVE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649864106","title":"Mesoblast Requests Modular Review of BLA for Rexlemestrocel-l in End-stage Heart Failure with LVAD","url":"https://stock-news.laohu8.com/highlight/detail?id=2649864106","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649864106?lang=en_us&edition=fundamental","pubTime":"2026-07-06 15:45","pubTimestamp":1783323913,"startTime":"0","endTime":"0","summary":"July 1 (Reuters) - Mesoblast Ltd::*REQUESTS MODULAR REVIEW OF BLA FOR REXLEMESTROCEL-L IN END-STAGE HEART FAILURE WITH LVAD*REXLEMESTROCEL-L RECEIVES ORPHAN DRUG AND RMAT DESIGNATIONS*Further company ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nRSD6tn3Cb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","MSB.AU","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649146316","title":"3 Founder Led ASX Stocks Retail Investors Are Watching For Management Alignment","url":"https://stock-news.laohu8.com/highlight/detail?id=2649146316","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649146316?lang=en_us&edition=fundamental","pubTime":"2026-07-06 06:25","pubTimestamp":1783290328,"startTime":"0","endTime":"0","summary":"With central banks turning slightly less aggressive, inflation pressures mixed across regions and services sectors holding up better than expected in many countries, investors are again paying closer attention to stock selection rather than just macro headlines. Founder-led companies can be especially interesting in this context, as leaders with significant personal stakes often focus on building long term legacies instead of chasing short term targets. This Founder-Led Companies screener is...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-asx-stocks-retail-investors-are-watching-for-m","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-asx-stocks-retail-investors-are-watching-for-m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FLT.AU","BK7501","BK7067","MQG.AU","MSB.AU","BK7043","ISBC","BK4211","BK7508","BK7070","AIPO","BK7042","BK7511","MAQ.AU","BK7046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648015660","title":"Why Mesoblast (ASX:MSB) Is Up 9.3% After FDA Accepts Modular BLA Review For Rexlemestrocel-L","url":"https://stock-news.laohu8.com/highlight/detail?id=2648015660","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648015660?lang=en_us&edition=fundamental","pubTime":"2026-07-04 00:35","pubTimestamp":1783096506,"startTime":"0","endTime":"0","summary":"In late June 2026, Mesoblast received a Biologics License Application filing number from the U.S. FDA and requested modular review for rexlemestrocel-L to prevent life-threatening gastrointestinal bleeding in end-stage heart failure patients supported by left ventricular assist devices, building on its Orphan Drug and RMAT designations.\nThe filing comes as new FDA draft guidance reiterates a flexible approach to therapies for rare, high-mortality conditions, potentially aligning closely with...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/why-mesoblast-asxmsb-is-up-93-after-fda-accepts-modular-bla","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/why-mesoblast-asxmsb-is-up-93-after-fda-accepts-modular-bla","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB","BK7508","MSB.AU","BK7501","BK4585","BK4006","BK7067","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648502120","title":"Founder Led Stocks Retail Investors Are Watching In Australia Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2648502120","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648502120?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:47","pubTimestamp":1782992868,"startTime":"0","endTime":"0","summary":"With inflation trends shifting, central banks reassessing rate paths and growth signals looking mixed, many investors are looking for leaders who are personally tied to the long term success of their companies. Founder led stocks can offer that kind of alignment because the people calling the shots often have much of their own wealth on the line too. This article uses a Founder Led Companies screener that focuses on that commitment. It then highlights 3 stocks from the list that stand out and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-retail-investors-are-watching-in-australi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-retail-investors-are-watching-in-australi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IISV.AU","BK7508","BK7511","OZR.AU","VAS.AU","IMLC.AU","IOZ.AU","IIGF.AU","MAQ.AU","ISBC","ZYAU.AU","DACE.AU","BK7043","MSB.AU","BEAR.AU","E200.AU","QFN.AU","BBOZ.AU","SLF.AU","BK7067","OZF.AU","BK7042","MQG.AU","BK4211","GEAR.AU","XJO.AU","BK7070","XKO.AU","GIVE.AU","EIGA.AU","BK7501","VAP.AU","FLT.AU","XAO.AU","QRE.AU","STW.AU","BK7046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648957086","title":"Is Mesoblast (ASX:MSB) Undervalued Following FDA Progress For Rexlemestrocel L?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648957086","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648957086?lang=en_us&edition=fundamental","pubTime":"2026-07-02 13:40","pubTimestamp":1782970812,"startTime":"0","endTime":"0","summary":"Why this FDA milestone matters for Mesoblast\nMesoblast (ASX:MSB) stock is in focus after the US FDA assigned a Biologics License Application filing number for rexlemestrocel-L and accepted a modular review request for patients with LVAD-related risks.\nThis regulatory step, supported by existing Orphan Drug and Regenerative Medicine Advanced Therapy designations, provides formal structure around the approval process for Mesoblast’s late-stage heart failure program and clarifies the path for...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/is-mesoblast-asxmsb-undervalued-following-fda-progress-for-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/is-mesoblast-asxmsb-undervalued-following-fda-progress-for-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4097","BK7067","BK4585","BK7508","MSB","LU2065732104.USD","MSB.AU","PRGS","BK7501","LABU","BK4006","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174776615","title":"Stock Track | Mesoblast Soars 5.12% Intraday on FDA BLA Filing Number for Rexlemestrocel-L Heart Failure Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1174776615","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174776615?lang=en_us&edition=fundamental","pubTime":"2026-07-01 11:48","pubTimestamp":1782877717,"startTime":"0","endTime":"0","summary":"MESOBLAST LTD (MSB.AU) shares soared 5.12% during intraday trading on Wednesday, driven by a significant regulatory milestone for its lead therapy candidate.The biotech company announced it received...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648259980","title":"Mesoblast Receives Biologics License Application Filing Number From US FDA; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648259980","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648259980?lang=en_us&edition=fundamental","pubTime":"2026-07-01 10:01","pubTimestamp":1782871305,"startTime":"0","endTime":"0","summary":"Mesoblast  received a biologics license application  filing number from the US Food and Drug Administration  for rexlemestrocel-L in the prevention of gastrointestinal bleeding due to right ventricular dysfunction in end-stage heart failure patients with a left ventricular assist device, according to a Wednesday filing with the Australian bourse.BLA filing number is a six-digit tracking number issued by the FDA to identify and monitor a formal request to market a biologic product.The company also requested a modular review of its BLA for the therapy, the filing said.Shares rose 3% in morning trade on Wednesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BLA.AU","BK4139","MESO","MSB.AU","BK4585","BK7067","BK7501","BK4588","BK7508","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648595279","title":"Mesoblast Wins FDA BLA Filing Number for Rexlemestrocel-l, Seeks Modular Review in LVAD Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2648595279","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648595279?lang=en_us&edition=fundamental","pubTime":"2026-07-01 09:02","pubTimestamp":1782867730,"startTime":"0","endTime":"0","summary":"Mesoblast wins FDA BLA filing number for rexlemestrocel-L, seeks modular review in LVAD patientsMesoblast received an FDA BLA filing number for rexlemestrocel-L to prevent life-threatening GI bleeding","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL2TytfJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","BK7067","BK4585","IE00BN0W2W23.USD","MSB.AU","LU0314104364.USD","SG9999014021.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK7508","BK4112","SG9999014005.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","NDAQ","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BKPKM429.USD","BK7501","SG9999014039.USD","SG9999014013.SGD","BK4588","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648593394","title":"Mesoblast - Requests Modular Review of Bla for Rexlemestrocel-l in End-stage Heart Failure with Lvad","url":"https://stock-news.laohu8.com/highlight/detail?id=2648593394","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648593394?lang=en_us&edition=fundamental","pubTime":"2026-07-01 07:56","pubTimestamp":1782863813,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nFWN4320X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","MESO","BK4139","MSB.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648593343","title":"Mesoblast - Rexlemestrocel-l Receives Orphan Drug and Rmat Designations","url":"https://stock-news.laohu8.com/highlight/detail?id=2648593343","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648593343?lang=en_us&edition=fundamental","pubTime":"2026-07-01 07:56","pubTimestamp":1782863813,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nFWN4320X2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","MESO","BK7508","MSB.AU","BK4139","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648561173","title":"Founder Led Stocks With Long Term Skin In The Game","url":"https://stock-news.laohu8.com/highlight/detail?id=2648561173","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648561173?lang=en_us&edition=fundamental","pubTime":"2026-07-01 01:09","pubTimestamp":1782839352,"startTime":"0","endTime":"0","summary":"When inflation, energy prices and growth signals keep pulling in different directions, it can help to back leaders whose incentives are closely tied to long term outcomes. Founder led companies often fit that profile, with decision makers who typically think in decades, not quarters. While markets react to shifting inflation expectations from South Africa to France and to changing energy and commodity costs, this Founder Led Companies screener focuses on firms where leadership has deep...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-with-long-term-skin-in-the-game","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-with-long-term-skin-in-the-game","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7043","BK7501","MAQ.AU","MSB.AU","BK7070","BK7067","BK7511","BK7508","MQG.AU","FLT.AU","BK7042","BK7046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647896305","title":"3 Founder Led Australian Stocks With Insider Skin In The Game","url":"https://stock-news.laohu8.com/highlight/detail?id=2647896305","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647896305?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:15","pubTimestamp":1782735302,"startTime":"0","endTime":"0","summary":"Founder led stocks bring something different to your portfolio: leaders with skin in the game who often think in decades, not quarters. With rates, inflation signals and demand trends shifting across the UK, US, Europe and Asia, many investors are looking for businesses where leadership is personally invested in long term outcomes. This Founder-Led Companies screener focuses on exactly that, identifying companies where the person in charge is deeply tied to the equity story. In this article,...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-with-insider-skin-in-the-gam","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/3-founder-led-australian-stocks-with-insider-skin-in-the-gam","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7043","BK7067","IMLC.AU","QFN.AU","IIGF.AU","E200.AU","DACE.AU","BK7046","BK7511","GIVE.AU","XJO.AU","VAP.AU","VAS.AU","BBOZ.AU","BK7070","XKO.AU","MQG.AU","BK7042","IOZ.AU","QRE.AU","GEAR.AU","IISV.AU","MSB.AU","XAO.AU","FLT.AU","OZF.AU","MAQ.AU","EIGA.AU","OZR.AU","BK7501","BEAR.AU","BK7508","SLF.AU","STW.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646311964","title":"Founder Led Stocks Why Investors Are Looking At Flight Centre And 2 More","url":"https://stock-news.laohu8.com/highlight/detail?id=2646311964","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646311964?lang=en_us&edition=fundamental","pubTime":"2026-06-28 10:14","pubTimestamp":1782612867,"startTime":"0","endTime":"0","summary":"With inflation, interest rates and global growth all pulling investors in different directions, it can help to focus on something more tangible: founder commitment. Founder led companies often have leaders whose wealth and reputation are closely tied to long term results, which can encourage disciplined capital allocation through shifting cycles. This Founder Led Companies screener is designed to highlight businesses where the person who started the company is still in the driving seat and...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-why-investors-are-looking-at-flight-centr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-why-investors-are-looking-at-flight-centr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7046","BK7067","BK7511","ARTY","BK7508","BK7043","BK7070","AIPO","MSB.AU","MQG.AU","AGIX","BK7501","FLT.AU","ISBC","BK7042","CHAT","MAQ.AU","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646533346","title":"3 Promising ASX Penny Stocks With Over A$60M Market Cap","url":"https://stock-news.laohu8.com/highlight/detail?id=2646533346","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646533346?lang=en_us&edition=fundamental","pubTime":"2026-06-26 10:05","pubTimestamp":1782439509,"startTime":"0","endTime":"0","summary":"As Australian shares edge up slightly, defying global market volatility, investors are keenly watching for opportunities that align with current economic conditions. Penny stocks, while an old term, remain a relevant investment area for those seeking value in smaller or less-established companies. By focusing on robust financials and growth potential, these stocks can offer both stability and upside—qualities that make them attractive to investors looking to uncover hidden value in the market.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-drx/diatreme-resources-shares/news/3-promising-asx-penny-stocks-with-over-a60m-market-cap-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-drx/diatreme-resources-shares/news/3-promising-asx-penny-stocks-with-over-a60m-market-cap-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ZYAU.AU","IISV.AU","XAO.AU","VAS.AU","EIGA.AU","BK7095","VAP.AU","BK7508","BK7121","XKO.AU","IIGF.AU","DRX.AU","BK7067","MSB.AU","IMLC.AU","QRE.AU","IOZ.AU","E200.AU","OZF.AU","QFN.AU","DACE.AU","BEAR.AU","XJO.AU","GIVE.AU","BBOZ.AU","UOS.AU","BK7501","GEAR.AU","OZR.AU","STW.AU","SLF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646847745","title":"Mesoblast Draws $50 Million From Facility Provided by Shareholder","url":"https://stock-news.laohu8.com/highlight/detail?id=2646847745","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646847745?lang=en_us&edition=fundamental","pubTime":"2026-06-25 09:02","pubTimestamp":1782349359,"startTime":"0","endTime":"0","summary":"Mesoblast  said it drew down $50 million from a five-year facility provided by Gregory George, a shareholder and director of the company, according to a Thursday filing with the Australian bourse.The credit line carries a fixed interest rate of 8% per year, which marks \"a substantial reduction\" from prior facilities, the company said.Mesoblast had $122 million of cash at the end of March and \"is well funded to invest in its commercial operations and growth pipeline,\" it said.The company's shares fell nearly 2% in recent Thursday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","MSB.AU","BK7501","BK4139","MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646847290","title":"Press Release: Mesoblast Draws US$50 Million from Five-year Non-dilutive Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2646847290","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646847290?lang=en_us&edition=fundamental","pubTime":"2026-06-25 08:59","pubTimestamp":1782349140,"startTime":"0","endTime":"0","summary":"Optimized capital structure, retiring short-term maturing debtWell-funded for commercial operations and growth pipelineNEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:M","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB","BK4232","MSB.AU","BK7501","BK7508","BK4022","MESO","BK4139","BK4150","MSC","BK4575","R","BK4006","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645965180","title":"Mesoblast (ASX:MSB) Is Up 9.2% After Ryoncil’s Near-US$100m Debut And Revascor FDA Progress – Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2645965180","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645965180?lang=en_us&edition=fundamental","pubTime":"2026-06-21 00:29","pubTimestamp":1781972983,"startTime":"0","endTime":"0","summary":"Earlier this week, Mesoblast reported that Ryoncil’s first-year US launch revenue approached about US$100 million, alongside continued FDA engagement on an accelerated-approval pathway and Biologics License Application for heart failure therapy Revascor.\nThis combination of early commercial traction for Ryoncil and active regulatory dialogue on Revascor has sharpened investor focus on Mesoblast’s broader cell therapy pipeline and execution risks.\nWe’ll now examine how Ryoncil’s early US...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-up-92-after-ryoncils-near-us100m-debut-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-up-92-after-ryoncils-near-us100m-debut-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4097","LABU","PRGS","LU2065732104.USD","BK7067","BK7501","BK7508","BK4006","MSB.AU","BK4585","MSB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642259232","title":"Mesoblast Says JPMorgan Ceases to be Substantial Holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2642259232","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642259232?lang=en_us&edition=fundamental","pubTime":"2026-06-12 11:38","pubTimestamp":1781235489,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) said JPMorgan Chase and its affiliates ceased to be substantial holders of the firm on Tuesday, according to a Friday Australian bourse filing.Its shares rose 1% in recent trading on Friday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PGF","LU2462157665.USD","LU1894683348.USD","JPMO","JPM","LU2237443895.HKD","LU2552382215.SGD","JPO","IE00BKDWB100.SGD","IE00BFXG1179.USD","LU0976567544.SGD","JPX","LU2213496289.HKD","LU0211326755.USD","LU1551013342.USD","LU1670628061.USD","BK4550","LU2430703095.HKD","LU1670627923.USD","LU1974910355.USD","IE00BBT3K403.USD","LU0868494708.USD","LU2023250504.SGD","LU2357305700.SGD","LU1261432733.SGD","LU0345770993.USD","LU2430703251.USD","MSB.AU","LU2237443465.HKD","LU2237443622.USD","LU0211326839.USD","LU0256863902.USD","LU1119994496.HKD","LU0417517546.SGD","LU1244550221.USD","LU1914381329.SGD","LU1162221912.USD","LU2237443549.SGD","MESO","LU0211331839.USD","IE00BLSP4452.SGD","LU2211815571.USD","IE00BDCRKT87.USD","LU0048584097.USD","LU1116320737.USD","LU0859254822.USD","IE0034235295.USD","BK4139","LU1668664300.SGD","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":184,"code":"91000000","status":"200"}]}}